Page last updated: 2024-11-05

pirinixic acid and Injury, Myocardial Reperfusion

pirinixic acid has been researched along with Injury, Myocardial Reperfusion in 9 studies

pirinixic acid: structure

Research Excerpts

ExcerptRelevanceReference
" Langendorff-perfused hearts of rats pretreated with the selective PPAR-α agonist WY-14643 (WY, pirinixic acid; 3 mg·(kg body mass)·day(-1); 5 days) were subjected to 30 min ischaemia - 2 h reperfusion with or without the phosphatidylinositol 3-kinase (PI3K)-Akt inhibitor wortmannin for the evaluation of functional (left ventricular developed pressure, LVDP) recovery, infarct size (IS), and reperfusion-induced arrhythmias."3.78PPAR-alpha activation as a preconditioning-like intervention in rats in vivo confers myocardial protection against acute ischaemia-reperfusion injury: involvement of PI3K-Akt. ( Adameová, A; Barlaka, E; Carnická, S; Galatou, E; Kelly, T; Khandelwal, VK; Lazou, A; Ledvényiová, V; Nemčeková, M; Ravingerová, T, 2012)
"During reperfusion, the incidence of arrhythmia was higher in the control group compared with the WY-14643 group (9/10 versus 3/10, P<0."1.43Protective Effect of Peroxisome Proliferator-Activated Receptor α Activation against Cardiac Ischemia-Reperfusion Injury Is Related to Upregulation of Uncoupling Protein-3. ( Kim, HJ; Kim, JW; Kwak, YL; Lee, H; Song, JW, 2016)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's5 (55.56)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barlaka, E3
Ledvényiová, V4
Galatou, E3
Ferko, M2
Čarnická, S4
Ravingerová, T4
Lazou, A3
Nemčeková, M3
Muráriková, M1
Chytilová, A1
Mandíková, P1
Adameová, A2
Kolář, F1
Song, JW1
Kim, HJ1
Lee, H1
Kim, JW1
Kwak, YL1
Bulhak, AA2
Jung, C1
Ostenson, CG1
Lundberg, JO1
Sjöquist, PO2
Pernow, J2
Kelly, T1
Khandelwal, VK1
Xu, CB1
Edvinsson, L1
Yeh, CH1
Chen, TP1
Lee, CH1
Wu, YC1
Lin, YM1
Lin, PJ1
Wayman, NS1
Hattori, Y1
McDonald, MC1
Mota-Filipe, H1
Cuzzocrea, S1
Pisano, B1
Chatterjee, PK1
Thiemermann, C1

Other Studies

9 other studies available for pirinixic acid and Injury, Myocardial Reperfusion

ArticleYear
Delayed cardioprotective effects of WY-14643 are associated with inhibition of MMP-2 and modulation of Bcl-2 family proteins through PPAR-α activation in rat hearts subjected to global ischaemia-reperfusion.
    Canadian journal of physiology and pharmacology, 2013, Volume: 91, Issue:8

    Topics: Animals; Heart Function Tests; In Vitro Techniques; Male; Matrix Metalloproteinase 2; Matrix Metallo

2013
Treatment of rats with hypolipidemic compound pirinixic acid protects their hearts against ischemic injury: are mitochondrial K(ATP) channels and reactive oxygen species involved?
    Physiological research, 2013, Volume: 62, Issue:5

    Topics: Animals; Cardiotonic Agents; Cytoprotection; Disease Models, Animal; Hypolipidemic Agents; Lipid Per

2013
Upregulation of genes involved in cardiac metabolism enhances myocardial resistance to ischemia/reperfusion in the rat heart.
    Physiological research, 2013, Volume: 62, Issue:Suppl 1

    Topics: Animals; Male; Myocardial Reperfusion Injury; Myocardium; PPAR alpha; Pyrimidines; Rats; Rats, Wista

2013
Protective Effect of Peroxisome Proliferator-Activated Receptor α Activation against Cardiac Ischemia-Reperfusion Injury Is Related to Upregulation of Uncoupling Protein-3.
    Oxidative medicine and cellular longevity, 2016, Volume: 2016

    Topics: Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Cell Hypoxia; Cell Line; Cell Survival; Coronary

2016
PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:3

    Topics: Androstadienes; Animals; Blood Glucose; Body Weight; Cardiotonic Agents; Diabetes Mellitus, Type 2;

2009
PPAR-alpha activation as a preconditioning-like intervention in rats in vivo confers myocardial protection against acute ischaemia-reperfusion injury: involvement of PI3K-Akt.
    Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:8

    Topics: Androstadienes; Animals; Arrhythmias, Cardiac; Chymases; Disease Models, Animal; Male; Myocardial In

2012
Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
    Basic research in cardiology, 2006, Volume: 101, Issue:3

    Topics: Animals; Blood Pressure; Endothelin-1; Enzyme Inhibitors; Heart Rate; Immunoblotting; Male; Myocardi

2006
Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators.
    Shock (Augusta, Ga.), 2006, Volume: 26, Issue:3

    Topics: Animals; Apoptosis; Cardiopulmonary Bypass; Caspase 3; Caspases; Cell Adhesion Molecules; Cytokines;

2006
Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002, Volume: 16, Issue:9

    Topics: Adult; Animals; Cardiotonic Agents; Cell Adhesion Molecules; Cell Line; Cells, Cultured; Chemokine C

2002